INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
LL

Lin Shao-Lee

Director, Chief Executive OfficerCIK 0001725092

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 7
Max Insider Score33
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$30K
1,087 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Cue Biopharma, Inc.Director, Chief Executive Officer · Aug 14, 2026
33
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL
$275K
10.0K sh
Oct 12, 2026
Oct 14, 2026
traded Oct 12, 2026
+2d
SEC FORM 4

Evidence

13
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Option exercise
M—
109.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

29
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$160K
5,775 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

25
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$147K
5,423 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

25
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$67K
2,375 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

28
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$308K
10.5K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

21
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Option exercise
M—
109.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

32
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$924K
34.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence